ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

A Agilent Technologies

137.74
1.37 (1.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Agilent Technologies NYSE:A NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  1.37 1.00% 137.74 138.36 135.00 136.45 754,946 21:49:50

Agilent Brings Greater Clarity and Speed to Chemical Imaging

01/10/2018 4:00pm

Business Wire


Agilent Technologies (NYSE:A)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Agilent Technologies Charts.

Breakthrough System Takes Brand New Approach

Agilent Technologies Inc. (NYSE: A) today introduced a new approach to chemical imaging that will bring greater clarity and unprecedented speed to pharmaceutical, biomedical, food, and materials science.

The Agilent 8700 Laser Direct Infrared (LDIR) chemical imaging system represents a breakthrough in both chemical imaging and spectral analysis.

“This ‘walk-up’ solution provides high-definition chemical imaging more rapidly and accurately than ever, to aid in analyzing the composition of tablets, laminates, tissues, polymers, and fibers,” said Phil Binns, vice president and general manager of Agilent’s Spectroscopy division. “With this information, scientists can analyze more samples and in greater detail in minutes instead of hours.”

Binns noted that the new system would have a significant impact on pharmaceutical laboratories in particular “scientists will be able to make more informed decisions—in less time—in product formulation development and trouble-shooting.”

Using the 8700 LDIR, scientists can obtain actionable information about active pharmaceutical ingredients, excipients, polymorphs, salts, and defects to enable users to quickly identify and resolve issues experienced during drug development. Simply put, the 8700 has the potential to enable labs to bring pharmaceutical products to market faster and with greater confidence in their formulations.

The 8700 LDIR combines unique Quantum Cascade Laser (QCL) technology with rapid scanning optics and intuitive Agilent Clarity software. Importantly, the system produces images free from laser coherence artifacts to provide high definition images of large areas.

The 8700 LDIR system’s compact size, lack of liquid nitrogen, and automated operation make high-definition chemical imaging accessible to operators of all levels. Now users can minimize time spent on sample analysis and data review, which leads to increased productivity. Simple load-and-go methods also save time and make it ideal for walk-up use in both commercial and academic settings.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenues of $4.47 billion in fiscal 2017 and employs 14,200 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to our Newsroom. Follow on LinkedIn, Twitter, and Facebook.

Agilent TechnologiesVictoria Wadsworth-Hansen, +1 408-553-2005+45 2933 6980victoria.wadsworth-hansen@agilent.com

1 Year Agilent Technologies Chart

1 Year Agilent Technologies Chart

1 Month Agilent Technologies Chart

1 Month Agilent Technologies Chart

Your Recent History

Delayed Upgrade Clock